Biocon falls nearly 6% on USFDA observations for Bengaluru facility
Following the drop in the stock price, the company's market valuation went down by Rs 2,202 crore to Rs 37,608 crore.
May 03, 2018, 17:15 PM IST
Following the drop in the stock price, the company's market valuation went down by Rs 2,202 crore to Rs 37,608 crore.
May 03, 2018, 17:15 PM IST